August 16, 2019. Dr. Mathioudakis was quoted in an article by INSIDER regarding the rising costs of insulin and the consequences of switching to older versions of insulin.
August 12, 2019 Dr. Mathioudakis was a panelist at an FDA workshop: “Precision Dosing: Defining the Need and Approaches to Deliver Individualized Drug Dosing in the Real-World Setting.”
August 7, 2019. Dr. Mathioudakis offers perspective piece on PracticeUpdate regarding a large clinical trial studying the effect of intensive glycemic control on functional outcomes in hospitalized patients with acute ischemic stroke.
May 26, 2019. Dr. Everett publishes first-author paper on her research examining differences in the relationship between socioeconomic and DKA readmissions amongst children and adults.
April 15, 2019. Dr. Mathioudakis offers perspective piece in Healio Endocrinology regarding a recent study evaluating early inpatient diabetes consultation on quality of glycemic control in hospitalized patients.
Feb 11. 2019. Dr. Mathioudakis offers perspective piece in Healio Endocrinology regarding a recent study published in Diabetes Care evaluating the use of GLP-1 agonists in hospitalized patients.
Feb 9, 2019. Dr. Everett delivers talk at UT Southwestern Endocrine Grand Rounds entitled “Targeting Patients with High Risk Type 1 Diabetes: High Risk, Potential for High Reward.”
Jan. 22, 2019. Dr. Mathioudakis featured in “Research Spotlight” in Practical Diabetology.
Oct. 28, 2018. Dr. Mathioudakis presented "Antihyperglycemic Agents and Cardiovascular Outcomes” and "Controversies in Diabetes Management: A1C Target in Patients with T2DM” at the Cardiometabolic Conference in Dhahran, Saudi Arabia
April, 20, 2018. Dr. Mathioudakis discusses findings of team’s publication on glycemic control and wound healing in Healio Endocrinology.
June 6, 2017. Dr. Mathioudakis presents “Real Time Model of Insulin-Association Hypoglycemia” at a Symposium on Hypoglycemia Prediction Models for Risk Stratification- Prediction to Prevention at the 77th Scientific Session of the American Diabetes Association in San Diego, California.
Sept. 19, 2016. Dr. Mathioudakis presents “Development of an Ambulatory Diabetes Medication Smartset,” Physicians Advisory Council, Epic User Group Meeting in Verona, Wisconsin.
December 7, 2015. Johns Hopkins Glucose Management Program receives Johns Hopkins Innovation in Clinical Care Award “in recognition of hospitalwide impact on diabetes patient care and safety. The team’s success has attracted regional, national and international attention.”
May 17, 2015. Dr. Mathioudakis presents“Racial Differences of AKI of Hospitalized Adults with Diabetes: Analysis of the National Hospital Discharge Survey,” at the American Association of Clinical Endocrinologists Annual Scientific Meeting in Nashville, Tennessee.
March 20, 2015. Dr. Mathioudakis presents “Glucose Management in the Hospital: From Clinical Care to Systems Interventions” at the Quality Improvement Conference on Inpatient Glucose Management, Peking University People’s Hospital in Beijing, China.